ARCHIVES

Animas As Early Warning “Sentinels” Part Of DCE Study

This article is from The Cancer Letter archive.

Vol. 13 No. 31 | July 31, 1987

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

CDC Awaits Results Of Viral Cultures Of Bahama’s Serum For AIDs Contamination Before Taking Action

July 19, 1985

Diet Intervention Results Could Be Found In Months

April 4, 1986